share_log
Moomoo 24/7 ·  Apr 15 09:36
Immix Biopharma Announces Late-Breaking Nxc-201 Clinical Data Abstract Accepted for Oral Presentation at the 27TH Annual Meeting of the American Society of Gene and Cell Therapy (Asgct)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment